Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Krystal Biotech Inc (KRYS)

Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Krystal Biotech Inc 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 USA

www.krystalbio.com Employees: 275 P: 412-586-5830

Sector:

Medical

Description:

Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.

Key Statistics

Overview:

Market Capitalization, $K 7,094,358
Enterprise Value, $K 6,749,488
Shares Outstanding, K 28,998
Annual Sales, $ 290,520 K
Annual Net Income, $ 89,160 K
Last Quarter Sales, $ 97,800 K
Last Quarter Net Income, $ 79,370 K
EBIT, $ 158,240 K
EBITDA, $ 164,950 K
60-Month Beta 0.48
% of Insider Shareholders 13.70%
% of Institutional Shareholders 86.29%
Float, K 25,025
% Float 86.30%
Short Volume Ratio 0.54

Growth:

1-Year Return 41.09%
3-Year Return 206.43%
5-Year Return 317.49%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 455.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 2.66 on 11/03/25
Next Earnings Date 02/18/26
Earnings Per Share ttm 6.67
EPS Growth vs. Prev Qtr 106.20%
EPS Growth vs. Prev Year 192.31%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

KRYS Ratios

Ratio
Price/Earnings ttm 37.00
Price/Earnings forward 39.93
Price/Earnings to Growth N/A
Return-on-Equity % 19.36%
Return-on-Assets % 17.65%
Profit Margin % 30.69%
Debt/Equity 0.00
Price/Sales 24.63
Price/Cash Flow 53.22
Price/Book 6.29
Book Value/Share 39.24
Interest Coverage -1.63
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar